학술논문
First-line nivolumab + ipilimumab in advanced NSCLC: CheckMate 227 subpopulation analyses in Asian patients
Document Type
Article
Author
Source
In ESMO Open February 2022 7(1)
Subject
Language
ISSN
2059-7029